Name |
Requip Modutab 8 mg tablete s produljenim oslobađanjem |
Marketing Authorisation Number |
HR-H-864556067 |
Active Substance |
ropinirolklorid |
Composition |
jedna tableta s produljenim oslobađanjem sadrži 8 mg ropinirola u obliku ropinirolklorida |
Pharmaceutical Form |
tableta s produljenim oslobađanjem |
Manufacturer |
Glaxo Wellcome S.A., Aranda de Duero, Burgos, Španjolska |
Marketing Authorisation Holder |
GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
Marketing Authorisation Date |
20.08.2021 |
MA Period of Validity |
unlimited |
Classification Number |
UP/I-530-09/18-02/187 |
Registration Number |
381-12-01/70-21-13 |
Prescription |
na recept |
Type of prescription |
ponovljivi recept
|
Distribution |
u ljekarni |
Advertising to general public |
zabranjeno |
ATC Code |
N04BC04 |
Medicinal product marketed in the Croatia |
Da |
SmPC |
download |
PL |
download |